Vol 6, Supplement 2 (September 11, 2017): Chinese Clinical Oncology (Advances in Stereotactic Radio Surgery-Guest Editors: Kevin L. M. Chua, David B. H. Tan, Melvin. L. K. Chua, Simon S. Lo)

Review Article

The optimism surrounding stereotactic body radiation therapy and immunomodulation
Hannah Tharmalingam, Peter J. Hoskin
Stereotactic body radiation therapy for prostate cancer—a review
Waqar Haque, E. Brian Butler, Bin S. Teh
Challenges in imaging assessment following liver stereotactic body radiotherapy: pitfalls to avoid in clinical practice
Connie Yip, Gary J. R. Cook, Kasia Owczarczyk, Vicky Goh
Emerging technologies in stereotactic body radiotherapy
Lijun Ma, Lei Wang, Chia-Lin Tseng, Arjun Sahgal
Advances in external beam stereotactic body radiotherapy: principle concerns in implementing a liver radiation program
Stewart Gaede, Michael I. Lock
Stereotactic radiosurgery of the brain: a review of common indications
Philip Gilbo, Isabella Zhang, Jonathan Knisely
Re-irradiation with stereotactic body radiation therapy (SBRT)
Morten Høyer
Stereotactic radiotherapy in oligometastatic cancer
Thomas A. C. Kennedy, Mark T. Corkum, Alexander V. Louie
Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases
Gargi Kothari, Alexander V. Louie, David Pryor, Ian Vela, Simon S. Lo, Bin S. Teh, Shankar Siva
Postoperative stereotactic body radiotherapy for spinal metastases
Majed Alghamdi, Chia-Lin Tseng, Sten Myrehaug, Pejman Maralani, Chris Heyn, Hany Soliman, Young Lee, Mark Ruschin, Leodante da Costa, Victor Yang, Mikki Campbell, Arjun Sahgal
Exploiting molecular genomics in precision radiation oncology: a marriage of biological and physical precision
Janice S. H. Tan, Xiaotian Lin, Kevin L. M. Chua, Paula Y. Lam, Khee-Chee Soo, Melvin L. K. Chua
Stereotactic body radiotherapy for early stage lung cancer—historical developments and future strategies
Kevin L. M. Chua, Iris Sin, Kam W. Fong, Melvin L. K. Chua, Hiroshi Onishi


The focused issue “Advances in Stereotactic Radio Surgery” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Kevin L. M. Chua, David B. H. Tan, Melvin. L. K. Chua and Simon S. Lo served as the unpaid Guest Editors for the focused issue.